Oasmia Pharmaceutical AB (OMX:OASM)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - OASM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - OASM

  • Market CapSEK0.000m
  • SymbolOMX:OASM
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINSE0000722365

Company Profile

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. The company produces novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives. The products and product candidates utilize a proprietary, nanoparticle formulation technology platform, XR17, that is designed to facilitate the administration of intravenously-delivered active pharmaceutical ingredients, without the addition of toxic solvents. Its product candidate, Apealea (paclitaxel micellar), has received market authorization in the European Union and other territories.Oasmia Pharmaceutical AB is a pharmaceutical company. It develops a new generation of drugs within human and veterinary oncology. It has two approved products: Paclical and Paccal Vet-CA1.

Latest OASM news

Currently there for this company. Visit our news hub for other news .